PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15050291-6	2004	Lowered tyrosine phosphorylation of IkappaBalpha may be due to a decrease in activity of p56(lck) and ZAP-70, since treatment with piceatannol, an inhibitor of syk and src family kinases, mimics age associated decline in tyrosine phosphorylation of IkappaBalpha in T cells from young donors.	3,3',4,5'-tetrahydroxystilbene	131-142	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	168-171	
12435267-6	2003	The following observations imply that Syk is such a kinase: (i) beta(2) integrins activated Syk in a Src-dependent manner, (ii) Syk was associated with Cbl much longer than Fgr was, and (iii) the Syk inhibitor piceatannol (3,4,3",5"-tetrahydroxy- trans -stilbene) abolished the Cbl-associated kinase activity in an in vitro assay.	3,3',4,5'-tetrahydroxystilbene	210-221	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	101-104	
12435267-6	2003	The following observations imply that Syk is such a kinase: (i) beta(2) integrins activated Syk in a Src-dependent manner, (ii) Syk was associated with Cbl much longer than Fgr was, and (iii) the Syk inhibitor piceatannol (3,4,3",5"-tetrahydroxy- trans -stilbene) abolished the Cbl-associated kinase activity in an in vitro assay.	3,3',4,5'-tetrahydroxystilbene	223-262	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	101-104	
14982949-3	2004	We found that Src inhibitor PP2 and Syk inhibitor piceatannol inhibited phagocytosis, macrophage-inflammatory protein-1alpha (MIP-1alpha) release, as well as phosphorylation of extracellular-regulated kinase (ERK) and Akt, consistent with Src/Syk involvement early in FcgammaR signaling.	3,3',4,5'-tetrahydroxystilbene	50-61	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	239-242	
21681336-8	2011	Compared with the control group, after treatment of HeLa cells with STAT3 inhibitor Piceatannol for 24, 48, 72, and 96 h, the cell viability decreased by 23.8%, 29.7%, 37.3% and 45.4% (all P < 0.05), respectively, while increase of c-SRC content could not reverse the inhibitory effect.	3,3',4,5'-tetrahydroxystilbene	84-95	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	235-240